
浏览全部资源
扫码关注微信
苏州医学院
收稿日期:1986-07-08,
纸质出版日期:1987-06
移动端阅览
朱寿彭, 郑斯英, 王崇道, 等. 浓缩铀UO2F2单次或多次摄入体内的蓄积诱发骨髓细胞突变效应[J]. 核技术, 1987,10(6):53-55,64.
Shoupeng Zhu, Siying Zheng, Chongdao Wang, et al. Retention and transference of enriched uranium UO2F2 administered once or consecutively and its mutagenic effect on bone marrow cells[J]. Nuclear techniques, 1987, 10(6): 53-55,64.
朱寿彭, 郑斯英, 王崇道, 等. 浓缩铀UO2F2单次或多次摄入体内的蓄积诱发骨髓细胞突变效应[J]. 核技术, 1987,10(6):53-55,64. DOI:
Shoupeng Zhu, Siying Zheng, Chongdao Wang, et al. Retention and transference of enriched uranium UO2F2 administered once or consecutively and its mutagenic effect on bone marrow cells[J]. Nuclear techniques, 1987, 10(6): 53-55,64. DOI:
在生产现场环境中,可溶性浓缩铀UO
2
F
2
有可能通过不同途径单次或多次吸收到机体内
[1]
,为了估价浓缩铀对机体产生的危害程度,有必要阐明UO
2
F
2
被机体摄入后在各主要器官组织的积累和转移动态规律,揭示其呈现的选择性蓄积部位。并探讨该核素诱发对骨髓细胞染色体畸变的损伤效应,为揭示UO
2
F
2
对机体的损伤特点和寻找促排治疗措施提供必要的依据。
Retention and transference of enriched uranium UO
2
F
2
were observed after iv once 20 mg/kg and ip 15 mg/kg qd×3d to Wistar male rats. The dynamic retention of radioactivity in the body showed that enriched uranium UO
2
F
2
was chiefly localized in kidney
and then in skeleton and liver. The activity of enriched uranium UO
2
F
2
in skeleton rose steadily while the concentration in kidney and liver droped. It was concluded that the retention peculiarity of enriched uranium was equal to that of natural uranium.
When enriched uranium UO
2
F
2
was accumulated in organism
it caused chromosome aberration on bone marrow cells. Results indicated that the chromosome aberration rates were elevated when the dose of enriched uranium UO
2
F
2
was increased
at the same time the cell division was depressed.
皆川洋二 , 原子力工业 , 13 , 10 , 45 ( 1976 )。
朱寿彭 等 , 核技术 , 4 , 47 ( 1980 )。
朱寿彭 等 , 中国药理学报 , 3 , 3 , 197 ( 1982 )。
朱寿彭 , 放射毒理学 , 第一版 , 北京 , 原子能出版社 , 1983 年,第 310 页。
S. R. Bernard et al. , ORNL -2304 , ( 1957 ).
0
浏览量
24
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621